Article: Martin Mattingly.(is president and chief executive officer of Ambrx Inc)(Brief Article)

Article: Trimeris appoints Martin Mattingly as CEO.
Pharma Marketletter;  November 26, 2007 ;     386 words ...US biopharmaceutical group Trimeris has appointed Martin Mattingly as its chief executive, effective immediately. Before joining Trimeris' Dr Mattingly, who also becomes a member of board of directors, was president of fellow US company Ambrx Pharmaceuticals.

Article: Trimeris reveals strategic plan.
Pharma Marketletter;  December 17, 2007 ;     602 words ... ... shift strategic direction, Trimeris still possesses significant financial assets that include substantial cash and revenue streams from the sale of Fuzeon in collaboration with Roche," said Martin Mattingly, chief executive of Trimeris.

Article: Trimeris Announces 2008 Strategic Plan.
Business Wire;  December 10, 2007 ;     700+ words ... ... include substantial cash and revenue streams from the sale of FUZEON in collaboration with Roche," said Martin Mattingly, Chief Executive Officer of Trimeris. "In addition, we believe that TRI-1144 has the potential to be a valuable product ...

Article: Ambrx at turning point because of big-pharma deal? VP of ...
San Diego Business Journal;  July 9, 2007 ;     700+ words ... ... s inception in 2003. Ambrx's rapid progress has been impressive, but still unsettling is why former chief executive Martin Mattingly left after just more than a year--especially considering Mattingly's vocal enthusiasm for the firm ...

Article: Ambrx gains patent for technology to develop human growth ...
San Diego Business Journal;  May 29, 2006 ;     638 words ... ... proteins to improve them. "The man-made amino acid is like Velcro, and we can stick things to it," Chief Executive Officer Martin Mattingly has said, stressing that many diseases have the potential to be treated through proteins. "It lasts ...

Article: Corrections.(Correction Notice)
San Diego Business Journal;  January 30, 2006 ;     374 words ... ... JPMorgan Healthcare Conference featuring local biotech Ambrx, Inc. mistakenly referred to Chief Executive Officer and President Martin Mattingly as also being a founder of the company. The article also says the company expects its protein ...

Article: CHIEF EXECUTIVE.(appointments and promotions)(Brief ...
Chief Executive (U.S.);  September 1, 2000 ;     700+ words ... ... was named chairman, president, and chief executive of Scottsdale, AZ-based Dial Corp ... net * Gerry Burdo, 34, was named chief executive of NY-based Kozmo.com, an Internet ... Jr., 55, was named president and chief executive of Hartsville, SC-based Sonoco ...